Advertisement

Renal Failure, Dialysis, and Transplantation in Older Adults

  • John M. BarryEmail author
Chapter

Abstract

The application of comorbidity scales and the determination of performance status will assist in the assignment of treatment options for end-stage renal disease patients. Age matching of donors and recipients for deceased donor kidney transplantation will balance equity and justice. Recipient surgery is determined by vascular and urinary tract anatomy and function. Immunosuppression is tailored to immunologic competence. Management of post-transplant urologic problems is straightforward. Elderly people should not be automatically disqualified as renal donors.

Keywords

Calcineurin Inhibitor Mycophenolate Mofetil Delay Graft Function Ureteral Obstruction Benign Prostatic Obstruction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

Thank you to Megan Taylor, Administrative Coordinator for the Department of Urology, for 30 years of helping me write articles and book chapters and for helping me meet publication deadlines.

References

  1. 1.
    U.S. Renal Data System, USRDS. Annual data report: atlas of chronic kidney diseases and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.Google Scholar
  2. 2.
    Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaver kidney transplant. N Engl J Med. 1999;341:1725–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Ojo AO, Hanson JA, Meier-Kriesche H, et al. Survival of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001;12:589–97.PubMedGoogle Scholar
  4. 4.
    Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age-matching in elderly kidney transplant recipients – a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant. 2008;8:50–7.PubMedGoogle Scholar
  5. 5.
    Grams ME, Womer KL, Ugarte RM, et al. Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant. 2010;10:802–9.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Clinical practice guideline on shared decision-making in the appropriate initiation and withdrawal from dialysis. http://www.aacn.org/WD/Practice/Docs/CP_Guideline. Accessed 11 Sept 2011.
  7. 7.
    Beddhu S, Bruns FJ, Saul M, et al. A simple morbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med. 2000;108:609–13.PubMedCrossRefGoogle Scholar
  8. 8.
    Karnofsky DA, Burcherval JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of chemotherapeutic agents in cancer. New York, NY: Columbia University Press; 1949. p. 191–205.Google Scholar
  9. 9.
    Estimated prognosis for dialysis patients. http://www.nephron.org/cgi-bin/rpa_sdm.cgi. Accessed 9 Jan 2012.
  10. 10.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRefGoogle Scholar
  11. 11.
    Bunnapradist S, Danovich GM. Evaluation of adult kidney transplant candidates. Am J Kindey Dis. 2007;50:890–8.CrossRefGoogle Scholar
  12. 12.
    Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant. 2001;1 Suppl 2:3–95.PubMedGoogle Scholar
  13. 13.
    Recommended immunizations schedules for children, teens, and adults. http://www.immunize.org/catg.d/p2011.pdf. Accessed 3 Jan 2012.
  14. 14.
    Salem L, Anaya D, Veenstra D, Sullivan S, Flum D. Timing of colectomy for diverticulitis: a modeled decision analysis. J Am Coll Surg. 2004;199:904–12.PubMedCrossRefGoogle Scholar
  15. 15.
    Yoon SC, Hurst FP, Jindal RM, George SA, Neff RT, Agodoa LY, Kimmel PL, Abbott KC. Trends in renal transplantation in patients with human immunodeficiency virus infection: an analysis of the United States renal data system. Transplantation. 2011;91:864–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Barry JM. Kidney transplantation into patients with abnormal bladders. Transplantation. 2004;77:1120–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Kuroda N, Ohe C, Mikami S, Hes O, et al. Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol. 2011;26:1215–8.PubMedGoogle Scholar
  18. 18.
    Wagner MD, Prather JC, Barry JM. Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease. J Urol. 2007;177:2250–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Bennett WM, Elzinga L, Pulliam JP, Rashad AL, Barry JM. Cystic fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis. 1985;6:400–4.PubMedGoogle Scholar
  20. 20.
    Barry JM. Renal transplant recipient surgery. BJU Int. 2007;99:701–17.PubMedCrossRefGoogle Scholar
  21. 21.
    Ekser B, Furian L, Broggiato A, et al. Technical aspects of unilateral dual kidney transplantation from expanded criteria donors: experience of 100 patients. Am J Transplant. 2010;10:2000–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Tullis SG, Tran H, Guleria I, et al. The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann Surg. 2010;252:662–74.Google Scholar
  23. 23.
    Barry JM, Conlin MJ. Renal transplantation. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 10th ed. Philadelphia, PA: Elsevier; 2012. p. 1226–53.CrossRefGoogle Scholar
  24. 24.
    Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351:2715–29.PubMedCrossRefGoogle Scholar
  25. 25.
    Engels EA, Pfeiffer RM, Fraumeni Jr JF, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891–901.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Tong A, Chapman JR, Wong G, de Bruijn J, Craig JC. Screening and follow-up of living donors: a systematic review of clinical practice guidelines. Transplantation. 2011;92:962–72.PubMedGoogle Scholar
  27. 27.
    Zowanda ET. The aging kidney. In: Massry SG, Glassock RJ, editors. Textbook of nephrology. 2nd ed. Baltimore, MD: Williams and Wilkins; 1990. p. 996.Google Scholar
  28. 28.
    Gill J, Bunnapradist S, Danvovitch GM, et al. Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis. 2008;52(3):541–52.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of UrologyOregon Health and Science UniversityPortlandUSA

Personalised recommendations